Clinical Trial Update: Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for YH14755 in adults with dyslipidemia and type II diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• YH14755

Snippet

Sponsor: Yuhan Corporation | Conditions: Dyslipidemia, Type II Diabetes | Phase 3 | Status: COMPLETED